Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169

1.

Patient preferences of chemotherapy treatment options and tolerance of chemotherapy side effects in advanced stage lung cancer.

Islam KM, Anggondowati T, Deviany PE, Ryan JE, Fetrick A, Bagenda D, Copur MS, Tolentino A, Vaziri I, McKean HA, Dunder S, Gray JE, Huang C, Ganti AK.

BMC Cancer. 2019 Aug 27;19(1):835. doi: 10.1186/s12885-019-6054-x.

2.

Patient-Defined Treatment Success: Perspectives of Patients With Advanced-Stage Lung Cancer.

Islam KM, Deviany PE, Anggondowati T, Ryan JE, Fetrick A, Bagenda D, Copur MS, Tolentino A, Vaziri I, McKean HA, Dunder S, Gray JE, Huang CMD, Ganti AK.

J Oncol Pract. 2019 Sep;15(9):e758-e768. doi: 10.1200/JOP.18.00734. Epub 2019 Jul 19.

PMID:
31322990
3.

The role of targeted therapy in thymic carcinoma.

Krishnan M, Ganti AK.

J Oncol Pharm Pract. 2019 Oct;25(7):1712-1718. doi: 10.1177/1078155219852758. Epub 2019 Jun 4.

PMID:
31159657
4.

HPV Status and Survival in Non-Oropharyngeal Squamous Cell Carcinoma of the Head and Neck.

Wookey VB, Appiah AK, Kallam A, Ernani V, Smith LM, Ganti AK.

Anticancer Res. 2019 Apr;39(4):1907-1914. doi: 10.21873/anticanres.13299.

PMID:
30952732
5.

Association Between Treatment Facility Volume, Therapy Types, and Overall Survival in Patients With Stage IIIA Non-Small Cell Lung Cancer.

Kommalapati A, Tella SH, Appiah AK, Smith L, Ganti AK.

J Natl Compr Canc Netw. 2019 Mar 1;17(3):229-236. doi: 10.6004/jnccn.2018.7086.

PMID:
30865920
6.

Clinical prognostic model for older patients with advanced non-small cell lung cancer.

Ganti AK, Wang X, Stinchcombe TE, Wang Y, Bradley J, Cohen HJ, Kelly K, Paulus R, Ramalingam SS, Vokes EE, Pang H.

J Geriatr Oncol. 2019 Jul;10(4):555-559. doi: 10.1016/j.jgo.2019.02.007. Epub 2019 Feb 21.

PMID:
30797707
7.

Correction: Real-world management of patients with epidermal growth factor receptor (EGFR) mutation-positive non-small-cell lung cancer in the USA.

Li Y, Appius A, Pattipaka T, Feyereislova A, Cassidy A, Ganti AK.

PLoS One. 2019 Feb 20;14(2):e0212831. doi: 10.1371/journal.pone.0212831. eCollection 2019.

8.

Real-world management of patients with epidermal growth factor receptor (EGFR) mutation-positive non-small-cell lung cancer in the USA.

Li Y, Appius A, Pattipaka T, Feyereislova A, Cassidy A, Ganti AK.

PLoS One. 2019 Jan 4;14(1):e0209709. doi: 10.1371/journal.pone.0209709. eCollection 2019. Erratum in: PLoS One. 2019 Feb 20;14(2):e0212831.

9.

Impact of patient symptoms and caregiving tasks on psychological distress in caregivers for head and neck cancer (HNC).

Castellanos EH, Dietrich MS, Bond SM, Wells N, Schumacher K, Ganti AK, Murphy BA.

Psychooncology. 2019 Mar;28(3):511-517. doi: 10.1002/pon.4968. Epub 2019 Jan 20.

PMID:
30578599
10.

Adjuvant Systemic Therapy in Patients With Early-Stage NSCLC Treated With Stereotactic Body Radiation Therapy.

Ernani V, Appiah AK, Marr A, Zhang C, Zhen W, Smith LM, Ganti AK.

J Thorac Oncol. 2019 Mar;14(3):475-481. doi: 10.1016/j.jtho.2018.11.018. Epub 2018 Nov 29.

PMID:
30503890
11.

Daily Lisinopril vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial.

Sio TT, Atherton PJ, Pederson LD, Zhen WK, Mutter RW, Garces YI, Ma DJ, Leenstra JL, Rwigema JM, Dakhil S, Bearden JD, van der Veen SJ, Ganti AK, Schild SE, Miller RC.

Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):686-696. doi: 10.1016/j.ijrobp.2018.10.035. Epub 2018 Nov 2.

12.

Hunting for transcription factors: STAT3 decoy in non-small cell lung cancer.

Carmicheal J, Kaur S, Batra SK, Ganti AK.

Transl Lung Cancer Res. 2018 Sep;7(Suppl 3):S254-S257. doi: 10.21037/tlcr.2018.09.06. No abstract available.

13.

NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018.

Kalemkerian GP, Loo BW, Akerley W, Attia A, Bassetti M, Boumber Y, Decker R, Dobelbower MC, Dowlati A, Downey RJ, Florsheim C, Ganti AKP, Grecula JC, Gubens MA, Hann CL, Hayman JA, Heist RS, Koczywas M, Merritt RE, Mohindra N, Molina J, Moran CA, Morgensztern D, Pokharel S, Portnoy DC, Rhodes D, Rusthoven C, Santana-Davila R, Williams CC, Hoffmann KG, Hughes M.

J Natl Compr Canc Netw. 2018 Oct;16(10):1171-1182. doi: 10.6004/jnccn.2018.0079.

PMID:
30323087
14.

A Comparative Analysis of Survival and Funding Discrepancies in Cancers with High Mortality.

Hall BR, Cannon A, Atri P, Wichman CS, Smith LM, Kumar S, Batra SK, Wang H, Ganti AK, Sasson AR, Are C.

Ann Surg. 2018 Sep 4. doi: 10.1097/SLA.0000000000003042. [Epub ahead of print]

PMID:
30188400
15.

Predictive biomarkers for immune checkpoint inhibitor therapy: we need to keep searching.

Huerter MM, Ganti AK.

J Thorac Dis. 2018 Jul;10(Suppl 18):S2195-S2197. doi: 10.21037/jtd.2018.06.144. No abstract available.

16.

Unusual Cause of Pediatric Vaginal Bleeding: Infantile Capillary Hemangioma of the Cervix.

Ganti AK, Ray J, Mooney KL, Zambrano E, Hillard PJA, Fok W.

J Pediatr Adolesc Gynecol. 2019 Feb;32(1):80-82. doi: 10.1016/j.jpag.2018.08.003. Epub 2018 Aug 11.

PMID:
30107231
17.
18.

Natural Killer/T-cell Neoplasms: Analysis of Incidence, Patient Characteristics, and Survival Outcomes in the United States.

Kommalapati A, Tella SH, Ganti AK, Armitage JO.

Clin Lymphoma Myeloma Leuk. 2018 Jul;18(7):475-479. doi: 10.1016/j.clml.2018.04.009. Epub 2018 May 4.

PMID:
29752210
19.

A prognostic scoring model for survival after locoregional therapy in de novo stage IV breast cancer.

Kommalapati A, Tella SH, Goyal G, Ganti AK, Krishnamurthy J, Tandra PK.

Breast Cancer Res Treat. 2018 Aug;170(3):677-685. doi: 10.1007/s10549-018-4802-2. Epub 2018 May 2.

PMID:
29721715
20.

Advanced pancreatic cancer: a meta-analysis of clinical trials over thirty years.

Hall BR, Cannon A, Atri P, Wichman CS, Smith LM, Ganti AK, Are C, Sasson AR, Kumar S, Batra SK.

Oncotarget. 2018 Apr 10;9(27):19396-19405. doi: 10.18632/oncotarget.25036. eCollection 2018 Apr 10.

21.

Preoperative Pulmonary Function Tests (PFTs) and Outcomes from Resected Early Stage Non-small Cell Lung Cancer (NSCLC).

Almquist D, Khanal N, Smith L, Ganti AK.

Anticancer Res. 2018 May;38(5):2903-2907.

PMID:
29715115
22.

Unclassifiable B-Cell Lymphoma With Symptomatic Hyperleukocytosis Managed With Leukapheresis.

Chintalacheruvu LM, Umakanthan JM, Hernandez T, Teruya B, Ganti AK.

J Oncol Pract. 2018 May;14(5):329-330. doi: 10.1200/JOP.2017.024836. Epub 2018 Apr 20. No abstract available.

PMID:
29676946
23.

Immunotherapy in treatment naïve advanced non-small cell lung cancer.

Ernani V, Ganti AK.

J Thorac Dis. 2018 Feb;10(Suppl 3):S412-S421. doi: 10.21037/jtd.2017.12.94. Review.

24.

Safety of long-term anticoagulation in patients with brain metastases.

Horstman H, Gruhl J, Smith L, Ganti AK, Shonka NA.

Med Oncol. 2018 Mar 1;35(4):43. doi: 10.1007/s12032-018-1101-z.

PMID:
29497873
25.

Weight Loss and Percutaneous Endoscopic Gastrostomy Tube Placement during Chemoradiotherapy for Locally Advanced Cancer of the Oropharynx Do Not Negatively Impact Outcomes.

Baine MJ, Dorius T, Bennion N, Smith L, Zhen W, Ganti AK.

Front Oncol. 2017 Dec 5;7:299. doi: 10.3389/fonc.2017.00299. eCollection 2017.

26.

Surgery for limited-stage small cell lung cancer: ready for prime-time?

Ernani V, Ganti AK.

J Thorac Dis. 2017 Oct;9(10):3576-3578. doi: 10.21037/jtd.2017.09.43. No abstract available.

27.

Epidermal Growth Factor Receptor Mutational Status and Brain Metastases in Non-Small-Cell Lung Cancer.

Bhatt VR, D'Souza SP, Smith LM, Cushman-Vokoun AM, Noronha V, Verma V, Joshi A, Chougule A, Jambhekar N, Kessinger A, Marr A, Patil V, Banavali SD, Ganti AK, Prabhash K.

J Glob Oncol. 2016 Jul 20;3(3):208-217. doi: 10.1200/JGO.2016.003392. eCollection 2017 Jun.

28.

Mortality following pancreatectomy for elderly rural veterans with pancreatic cancer.

Nayar P, Chandak A, Yu F, Sayles H, Ganti AK.

J Geriatr Oncol. 2017 Jul;8(4):284-288. doi: 10.1016/j.jgo.2017.05.001. Epub 2017 May 22.

PMID:
28545742
29.

Access to Cancer Specialist Care and Treatment in Patients With Advanced Stage Lung Cancer.

Ganti AK, Hirsch FR, Wynes MW, Ravelo A, Ramalingam SS, Ionescu-Ittu R, Pivneva I, Borghaei H.

Clin Lung Cancer. 2017 Nov;18(6):640-650.e2. doi: 10.1016/j.cllc.2017.04.010. Epub 2017 Apr 26.

PMID:
28522158
30.

Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells.

Macha MA, Rachagani S, Qazi AK, Jahan R, Gupta S, Patel A, Seshacharyulu P, Lin C, Li S, Wang S, Verma V, Kishida S, Kishida M, Nakamura N, Kibe T, Lydiatt WM, Smith RB, Ganti AK, Jones DT, Batra SK, Jain M.

Oncotarget. 2017 Mar 28;8(13):20961-20973. doi: 10.18632/oncotarget.15468.

31.

Lung cancer-A global perspective.

McIntyre A, Ganti AK.

J Surg Oncol. 2017 Apr;115(5):550-554. doi: 10.1002/jso.24532. Epub 2017 Apr 18. Review.

PMID:
28418583
32.

MUC16 Regulates TSPYL5 for Lung Cancer Cell Growth and Chemoresistance by Suppressing p53.

Lakshmanan I, Salfity S, Seshacharyulu P, Rachagani S, Thomas A, Das S, Majhi PD, Nimmakayala RK, Vengoji R, Lele SM, Ponnusamy MP, Batra SK, Ganti AK.

Clin Cancer Res. 2017 Jul 15;23(14):3906-3917. doi: 10.1158/1078-0432.CCR-16-2530. Epub 2017 Feb 14.

33.

Validation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials.

Wang X, Wang X, Hodgson L, George SL, Sargent DJ, Foster NR, Ganti AK, Stinchcombe TE, Crawford J, Kratzke R, Adjei AA, Kindler HL, Vokes EE, Pang H.

Oncologist. 2017 Feb;22(2):189-198. doi: 10.1634/theoncologist.2016-0121. Epub 2017 Feb 10.

34.

Postoperative mortality following multi-modality therapy for pancreatic cancer: Analysis of the SEER-Medicare data.

Nayar P, Chandak A, Gupta N, Yu F, Qiu F, Ganti AK, Are C.

J Surg Oncol. 2017 Feb;115(2):158-163. doi: 10.1002/jso.24472.

PMID:
28133817
35.

NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016.

VanderWalde N, Jagsi R, Dotan E, Baumgartner J, Browner IS, Burhenn P, Cohen HJ, Edil BH, Edwards B, Extermann M, Ganti AK, Gross C, Hubbard J, Keating NL, Korc-Grodzicki B, McKoy JM, Medeiros BC, Mrozek E, O'Connor T, Rugo HS, Rupper RW, Shepard D, Silliman RA, Stirewalt DL, Tew WP, Walter LC, Wildes T, Bergman MA, Sundar H, Hurria A.

J Natl Compr Canc Netw. 2016 Nov;14(11):1357-1370.

PMID:
27799507
36.

Activity of single-agent decitabine in atypical chronic myeloid leukemia.

Hausmann H, Bhatt VR, Yuan J, Maness LJ, Ganti AK.

J Oncol Pharm Pract. 2016 Dec;22(6):790-794. Epub 2015 Sep 15.

PMID:
26378157
37.

Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012.

Pang HH, Wang X, Stinchcombe TE, Wong ML, Cheng P, Ganti AK, Sargent DJ, Zhang Y, Hu C, Mandrekar SJ, Redman MW, Manola JB, Schilsky RL, Cohen HJ, Bradley JD, Adjei AA, Gandara D, Ramalingam SS, Vokes EE.

J Clin Oncol. 2016 Nov 20;34(33):3992-3999. doi: 10.1200/JCO.2016.67.7088. Epub 2016 Sep 30.

38.

Resected small cell lung cancer-time for more?

Marr AS, Zhang C, Ganti AK.

J Thorac Dis. 2016 Aug;8(8):E755-7. doi: 10.21037/jtd.2016.07.17.

39.

Resected small cell lung cancer-what do we do next?

Marr AS, Ganti AK.

Ann Transl Med. 2016 Aug;4(15):288. doi: 10.21037/atm.2016.05.41. No abstract available.

40.

Weekly vinorelbine and paclitaxel in older patients with advanced non-small cell lung cancer: A phase II Fred and Pamela Buffet Cancer Center Clinical Trials Network study.

Huerter MM, Meza JL, Copur MS, Tolentino A, Marr AS, Ketcham M, DeSpiegelaere H, Kruse S, Kos ME, Swenson K, Radniecki SE, Kessinger A, Ganti AK.

J Geriatr Oncol. 2017 Jan;8(1):18-22. doi: 10.1016/j.jgo.2016.07.006. Epub 2016 Aug 1.

PMID:
27491498
41.

Anaplastic Thyroid Carcinoma: Light at the End of the Tunnel?

Ganti AK.

J Oncol Pract. 2016 Jun;12(6):519-20. doi: 10.1200/JOP.2016.012880. No abstract available.

PMID:
27288465
42.
43.

Associations of Circulating Cytokines and Chemokines With Cancer Mortality in Men With Rheumatoid Arthritis.

England BR, Sokolove J, Robinson WH, Thiele GM, Ganti AK, Sayles H, Michaud K, Caplan L, Davis LA, Cannon GW, Sauer B, Singh N, Blair Solow E, Reimold AM, Kerr GS, Schwab P, Baker JF, Mikuls TR.

Arthritis Rheumatol. 2016 Oct;68(10):2394-402. doi: 10.1002/art.39735.

44.

Concurrent chemoradiotherapy in older adults with squamous cell head & neck cancer: Evidence and management.

Verma V, Ganti AK.

J Geriatr Oncol. 2016 May;7(3):145-53. doi: 10.1016/j.jgo.2016.01.010. Epub 2016 Feb 28. Review.

PMID:
26924572
45.

Multimodality Therapy for Limited-Stage Small-Cell Lung Cancer.

Almquist D, Mosalpuria K, Ganti AK.

J Oncol Pract. 2016 Feb;12(2):111-7. doi: 10.1200/JOP.2015.009068. Review.

PMID:
26869647
46.

EGFR monoclonal antibodies in locally advanced head and neck squamous cell carcinoma: What is their current role?

Alorabi M, Shonka NA, Ganti AK.

Crit Rev Oncol Hematol. 2016 Mar;99:170-9. doi: 10.1016/j.critrevonc.2015.12.006. Epub 2015 Dec 19. Review.

PMID:
26797287
47.

MUC5AC interactions with integrin β4 enhances the migration of lung cancer cells through FAK signaling.

Lakshmanan I, Rachagani S, Hauke R, Krishn SR, Paknikar S, Seshacharyulu P, Karmakar S, Nimmakayala RK, Kaushik G, Johansson SL, Carey GB, Ponnusamy MP, Kaur S, Batra SK, Ganti AK.

Oncogene. 2016 Aug 4;35(31):4112-21. doi: 10.1038/onc.2015.478. Epub 2016 Jan 11.

48.

Early Stage Non-Small-Cell Lung Cancer in Octogenarian and Older Patients: A SEER Database Analysis.

Ganti AK, Shostrom V, Alorabi M, Zhen WK, Marr AS, Trujillo K, Islam KM, Lackner RP, Kessinger A.

Clin Lung Cancer. 2016 Jul;17(4):285-91. doi: 10.1016/j.cllc.2015.11.014. Epub 2015 Dec 1.

PMID:
26725852
49.

Emerging targeted therapies in non-small cell lung cancer.

Khanal N, Ganti AK.

Expert Rev Anticancer Ther. 2016;16(2):177-87. doi: 10.1586/14737140.2016.1126514. Epub 2016 Jan 18. Review.

PMID:
26618563
50.

Salivary Gland Cancers: Biology and Systemic Therapy.

Goyal G, Mehdi SA, Ganti AK.

Oncology (Williston Park). 2015 Oct;29(10):773-80. Review.

Supplemental Content

Loading ...
Support Center